RANDOMIZED CLINICAL TRIAL TO ASSESS THE ROLE OF VITAMIN C IN DEPRESSIO
- Conditions
- Health Condition 1: F332- Major depressive disorder, recurrent severe without psychotic features
- Registration Number
- CTRI/2019/06/019598
- Lead Sponsor
- Dr Kohima Aggarwal
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 60
1.Diagnosed cases of major depressive disorder according to ICD-10 visiting psychiatry OPD.
2.Both male and female patients between the ages of 18-65 years.
3.Patients willing to join the study after giving the informed consent
1.Patient not willing to give consent for the study.
2.Patients with any organic cause of depression.
3.Any major comorbidities like cardiovascular, renal and hepatic diseases.
4.Any other psychiatric comorbidities.
5.Special physiological conditions like pregnancy, and lactation.
6.Patients using drugs that may interact with Vitamin C like-bishydroxycoumarin and with Proxetine like- thioridazine, pimozide, tamoxifen, warfarin, NSAIDs, alcohol, tryptophan, monoamine oxidase inhibitors like- linezolid and intravenous methylene blue, triptans, lithium, fentanyl, tramadol, cimetidine, other SSRIs and SNRIs, phenobarbital, phenytoin, imipramine, risperidone and any other potential drug interaction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method